X Square Capital, LLC Cybin Inc. Transaction History

X Square Capital, LLC

  • $228 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$0.38 - $0.65 $8,360 - $14,300
22,000 Added 110.0%
42,000 $17,000
Q2 2023

Aug 14, 2023
BUY
$0.23 - $0.39 $1,150 - $1,950
5,000 Added 33.33%
20,000 $8,000
Q4 2022

Feb 02, 2023
BUY
$0.26 - $0.64 $1,300 - $3,200
5,000 Added 50.0%
15,000 $4,000
Q4 2021

Feb 14, 2022
BUY
$1.13 - $2.31 $11,299 - $23,100
10,000 New
10,000 $12,000

Others Institutions Holding CYBN

# of Institutions
8
Shares Held
66.1K
Call Options Held
0
Put Options Held
0
View Full List

About CYBIN INC.

CYBN Quotes by TradingView
  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $1.58B
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track X Square Capital, LLC Portfolio

Follow X Square Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of X Square Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on X Square Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email